SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 27 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $16,000 | -11.1% | 12,000 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $18,000 | +63.6% | 12,000 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $11,000 | -42.1% | 12,000 | 0.0% | 0.00% | -40.0% |
Q4 2019 | $19,000 | -53.7% | 12,000 | 0.0% | 0.01% | -54.5% |
Q3 2019 | $41,000 | -6.8% | 12,000 | 0.0% | 0.01% | -8.3% |
Q2 2019 | $44,000 | – | 12,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PARSONS CAPITAL MANAGEMENT INC/RI | 195,165 | $1,559,000 | 0.21% |
DAFNA Capital Management LLC | 27,412 | $219,000 | 0.19% |
Verity & Verity, LLC | 12,385 | $99,000 | 0.03% |
Baker Brothers Advisors | 219,298 | $1,752,000 | 0.02% |
Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 97,286 | $777,000 | 0.01% |
BRYN MAWR TRUST Co | 14,000 | $112,000 | 0.01% |
BlackRock Investment Management, LLC | 163 | $1,000 | 0.00% |
MORGAN STANLEY | 12,500 | $100,000 | 0.00% |